# Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma

> **NCT02951897** · NA · UNKNOWN · sponsor: **Third Military Medical University** · enrollment: 120 (estimated)

## Conditions studied

- Lung Adenocarcinoma, Stage I
- Diagnoses Diseases
- Circulating Tumor Cells
- Treatment

## Interventions

- **PROCEDURE:** lobectomy
- **PROCEDURE:** segmentecomy
- **DRUG:** chemotherapy（pemetrexed+CISPLATIN）
- **PROCEDURE:** Lymphadenectomy
- **OTHER:** CanPatrolTM to detect CTCs

## Key facts

- **NCT ID:** NCT02951897
- **Lead sponsor:** Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02951897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02951897, "Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02951897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*